POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 86 filers reported holding POSEIDA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29 | +38.1% | 12,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $21 | -43.2% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $37 | -42.2% | 12,000 | 0.0% | 0.00% | -50.0% |
| Q4 2022 | $64 | -99.8% | 12,000 | 0.0% | 0.01% | +50.0% |
| Q3 2022 | $42,000 | +35.5% | 12,000 | 0.0% | 0.00% | +33.3% |
| Q2 2022 | $31,000 | -42.6% | 12,000 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $54,000 | -34.1% | 12,000 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $82,000 | -5.7% | 12,000 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $87,000 | -27.5% | 12,000 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $120,000 | +4.3% | 12,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $115,000 | -12.9% | 12,000 | 0.0% | 0.01% | -23.1% |
| Q4 2020 | $132,000 | -17.5% | 12,000 | -33.3% | 0.01% | -23.5% |
| Q3 2020 | $160,000 | – | 18,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $2,692,000 | 1.92% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 380,606 | $982,000 | 0.30% |
| Pentwater Capital Management LP | 4,967,227 | $12,815,000 | 0.15% |
| Atom Investors LP | 55,827 | $144,000 | 0.06% |
| Corton Capital Inc. | 14,978 | $39,000 | 0.04% |
| Forefront Analytics, LLC | 23,370 | $61,000 | 0.03% |
| Delphia (USA) Inc. | 15,799 | $41,000 | 0.03% |
| Advisory Services Network, LLC | 259,571 | $670,000 | 0.02% |
| Laurion Capital Management LP | 545,700 | $1,408,000 | 0.02% |
| MCF Advisors LLC | 59,659 | $154,000 | 0.02% |